{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:39:56Z","timestamp":1789540796421,"version":"build-2803163510"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12888-014-0376-7","type":"journal-article","created":{"date-parts":[[2014,12,23]],"date-time":"2014-12-23T06:58:31Z","timestamp":1419317911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background"],"prefix":"10.1186","volume":"14","author":[{"given":"Francesca","family":"Brambilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Amianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Dalle Grave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Secondo","family":"Fassino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,24]]},"reference":[{"key":"376_CR1","unstructured":"NICE: Eating Disorders-Core Interventions in the treatment and management of anorexia nervosa, bulimia nervosa and related eating disorders. In: NICE Clinical Guideline No. 9, National Institute for Clinical Excellence\/Gaskell and the British Psychological Society, London\/London; 2011."},{"key":"376_CR2","volume-title":"A Guide to Treatments that Work","author":"TJ Wilson","year":"2007","unstructured":"Wilson TJ, Fairburn GC: Treatment for Eating Disorder. A Guide to Treatments that Work. Edited by: Nathan PE, Gorman JM. 2007, Oxford University Press, New York"},{"issue":"3","key":"376_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1176\/appi.ajp.2008.08040608","volume":"166","author":"CG Fairburn","year":"2009","unstructured":"Fairburn CG, Cooper Z, O\u2019Connor ME, Bohn K, Hawker DM, Wales JA, Palmer RL: Transdiagnostic Cognitive-Behavioral Therapy for patients with Eating Disorders: a two-site trial with 60-week follow-up. Am J Psychiatr. 2009, 166 (3): 311-319. 10.1176\/appi.ajp.2008.08040608.","journal-title":"Am J Psychiatr"},{"key":"376_CR4","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.beth.2009.01.006","volume":"41","author":"DL Safer","year":"2010","unstructured":"Safer DL, Robinson AH, Jo B: Outcome from a randomized controlled trial of group therapy for Binge Eating disorder: comparing Dialectical Behavior Therapy adapted for Binge Eating to an Active Comparison group therapy. Behav Ther. 2010, 41: 106-120. 10.1016\/j.beth.2009.01.006.","journal-title":"Behav Ther"},{"key":"376_CR5","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/15622975.2011.602720","volume":"12","author":"M Aigner","year":"2011","unstructured":"Aigner M, Treasure J, Kaye W, Kasper S, WFSBP Task Force On Eating Disorders: World Federation Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Eating Disorders. World J Biol Psychiatr. 2011, 12: 400-443. 10.3109\/15622975.2011.602720.","journal-title":"World J Biol Psychiatr"},{"key":"376_CR6","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/S0893-133X(99)00053-6","volume":"21","author":"WH Kaye","year":"1999","unstructured":"Kaye WH, Frank GK, McConaha C: Altered dopamine activity after recovery from restricting-type anorexia nervosa. Neuropsychopharmacol. 1999, 21: 503-506. 10.1016\/S0893-133X(99)00053-6.","journal-title":"Neuropsychopharmacol"},{"key":"376_CR7","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.biopsych.2005.05.003","volume":"58","author":"GK Frank","year":"2005","unstructured":"Frank GK, Bailer UF, Henry SE, Drevets V, Meltzer CC, Price JC, Mathis CA Wagner A, Hoge J, Ziolko S, Barbarich-Marsteller N, Weissfeld L, Kaye WH: Increased dopamine D2\/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11-CL] raclopride. Biol Psychiatr. 2005, 58: 908-912. 10.1016\/j.biopsych.2005.05.003.","journal-title":"Biol Psychiatr"},{"key":"376_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/sj.npp.1301443","volume":"33","author":"A Wagner","year":"2008","unstructured":"Wagner A, Aizenstein H, Mazurkewicz L, Fudge J, Frank GK, Putnam K, Bailer UF, Fischer L, Kaye WH: Altered insula response to taste stimuli in individuals recovered from restricting-type Anorexia Nervosa. Neuropsychopharmacol. 2008, 33: 513-523. 10.1038\/sj.npp.1301443.","journal-title":"Neuropsychopharmacol"},{"key":"376_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1001\/archpsyc.1984.01790150040007","volume":"41","author":"WH Kaye","year":"1984","unstructured":"Kaye WH, Ebert MH, Raleigh M, Lake R: Abnormalities in CNS monoamine metabolism in anorexia nervosa. Arch Gen Psychiatr. 1984, 41: 350-355. 10.1001\/archpsyc.1984.01790150040007.","journal-title":"Arch Gen Psychiatr"},{"key":"376_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0006-3223(88)90113-8","volume":"23","author":"WH Kaye","year":"1988","unstructured":"Kaye WH, Gwirtsman HE, George DT, Ebert H: 5HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain. Biol Psychiatr. 1988, 23: 102-105. 10.1016\/0006-3223(88)90113-8.","journal-title":"Biol Psychiatr"},{"key":"376_CR11","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1001\/archpsyc.1991.01810300068010","volume":"48","author":"WH Kaye","year":"1991","unstructured":"Kaye WH, Gwirtsman HE, George DT, Ebert H: Altered serotonin activity in anorexia nervosa after long-term weight recovery. Arch Gen Psychiatr. 1991, 48: 556-562. 10.1001\/archpsyc.1991.01810300068010.","journal-title":"Arch Gen Psychiatr"},{"key":"376_CR12","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1176\/appi.ajp.158.7.1152","volume":"158","author":"WH Kaye","year":"2001","unstructured":"Kaye WH, Frank GK, Meltzer CC, Price JC, McKonaha CW, Crossan PJ, Klump KL, Rhodes L: Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa. Am J Psychiatr. 2001, 158: 1152-1155. 10.1176\/appi.ajp.158.7.1152.","journal-title":"Am J Psychiatr"},{"key":"376_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/eat.10135","volume":"33","author":"WH Kaye","year":"2003","unstructured":"Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M, McConaha CV, Kishore A: Anxiolitic effects of acute tryptophan depletion in anorexia nervosa. Int J Eat Dis. 2003, 33: 257-267. 10.1002\/eat.10135.","journal-title":"Int J Eat Dis"},{"key":"376_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0306-4530(00)00062-7","volume":"26","author":"F Brambilla","year":"2001","unstructured":"Brambilla F, Bellodi L, Arancio C, Ronchi P, Limonta D: Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach. Psychoneuroendocrinology. 2001, 26: 393-409. 10.1016\/S0306-4530(00)00062-7.","journal-title":"Psychoneuroendocrinology"},{"key":"376_CR15","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/sj.npp.1300430","volume":"29","author":"UF Bailer","year":"2004","unstructured":"Bailer UF, Price JC, Meltzer CC, Mathis C, Frank GK, Wissfeld L, McConaha CW, Henry SE, Brooks-Achenbach S, Barbarich NC, Kaye WH: Altered 5-HT2a receptor binding after recovery from bulimia-type anorexia nervosa: relationship to harm avoidance and drive for thinness. Neuropsychopharmacol. 2004, 29: 1143-1155. 10.1038\/sj.npp.1300430.","journal-title":"Neuropsychopharmacol"},{"key":"376_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/eat.20843","volume":"44","author":"UF Bailer","year":"2011","unstructured":"Bailer UF, Bloss C, Frank G, Meltzer C, Mathis CA, Geyer MA, Wagner A, Becker CR, Schork NJ, Kaye WH: 5-HT1A receptor binding is increased after recoveryfrom bulimia nervosa compared to control women and is associated with behavioural inhibition in both groups. Int J Eat Dis. 2011, 44: 477-487. 10.1002\/eat.20843.","journal-title":"Int J Eat Dis"},{"key":"376_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pscychresns.2012.06.010","volume":"211","author":"UF Bailer","year":"2013","unstructured":"Bailer UF, Frank GK, Price JC, Meltzer CC, Becker C, Mathis CA, Wagner A, Barbarich-Marsteller NC, Bloss CS, Putman K, Schork NJ, Gamst A, Kaye WH: Interaction between serotonin transporter and dopamine D2\/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatr Res. 2013, 211: 160-168. 10.1016\/j.pscychresns.2012.06.010.","journal-title":"Psychiatr Res"},{"key":"376_CR18","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(03)12378-1","volume":"361","author":"CG Fairburn","year":"2003","unstructured":"Fairburn CG, Harrison PJ: Eating Disorders. Lancet. 2003, 361: 407-416. 10.1016\/S0140-6736(03)12378-1.","journal-title":"Lancet"},{"key":"376_CR19","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/erv.664","volume":"13","author":"R Dalle Grave","year":"2005","unstructured":"Dalle Grave R: A multiple-step cognitive behaviour therapy for eating disorders. Eat Dis Rev. 2005, 13: 372-382. 10.1002\/erv.664.","journal-title":"Eat Dis Rev"},{"key":"376_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0165-1781(88)90013-3","volume":"23","author":"D Marazziti","year":"1988","unstructured":"Marazziti D: Pertugi G, Delitto J, Lenzi A, Maremmani I, Placidi GF, Cassano GB: High-affinity 3H-imiparmine binding sites: a possible state-dependent marker for major depression . Psychiatr Res. 1988, 23: 229-237. 10.1016\/0165-1781(88)90013-3.","journal-title":"Psychiatr Res"},{"key":"376_CR21","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/0024-3205(83)90370-3","volume":"32","author":"DE Sternberg","year":"1983","unstructured":"Sternberg DE, Heninger GR, Roth RH: Plasma homovanillic acid as an index of brain dopamine metabolism: Enhancement with debrisoquin. Life Sci. 1983, 32: 2447-2452. 10.1016\/0024-3205(83)90370-3.","journal-title":"Life Sci"},{"key":"376_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1001\/archpsyc.1987.01800220068010","volume":"44","author":"WM Glazer","year":"1987","unstructured":"Glazer WM, Charney DS, Heninger GR: Noradrenergic function in schizophrenia. Arch Gen Psychiatr. 1987, 44: 898-904. 10.1001\/archpsyc.1987.01800220068010.","journal-title":"Arch Gen Psychiatr"},{"key":"376_CR23","doi-asserted-by":"crossref","unstructured":"Rausch J, Johnson ME, Li J, Hutcheson J, Carr BM, Corley KM, Gowan AB, Smith J: Serotonin transporter kinetics correlated between human platelets and brain synaptosomes. Psychopharmacol 2005, 180:391.398.,","DOI":"10.1007\/s00213-005-2178-6"},{"key":"376_CR24","first-page":"165","volume":"50","author":"S Fassino","year":"2008","unstructured":"Fassino S, Amianto F, Ferrero A: Brief Adlerian psychodynamic psychotherapy: theoretical Issues and process indicators. Panminerva Med. 2008, 50: 165-175.","journal-title":"Panminerva Med"},{"key":"376_CR25","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1021\/ac00126a067","volume":"58","author":"GA Gerhardt","year":"1986","unstructured":"Gerhardt GA, Drebing CJ, Freedman R: Simultaneous determination of free homovanillic acid (HVA), 3-methoxy-4-hydroxyphenylglycol (MHPG) and vanyllilmandelic acid (VMA) in human plasma by HPLC coupled with dual electrode coulorimetric electrochemical detection. Anal Chem. 1986, 58: 2879-2883. 10.1021\/ac00126a067.","journal-title":"Anal Chem"},{"key":"376_CR26","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1192\/bjp.172.5.439","volume":"172","author":"P Monteleone","year":"1998","unstructured":"Monteleone P, Brambilla F, Bortolotti F, LaRocca A, Maj M: Prolactin response to d-fenfluramine is blunted in people with anorexia nervosa. Brit J Psychiatr. 1998, 172: 418-442. 10.1192\/bjp.172.5.439.","journal-title":"Brit J Psychiatr"},{"key":"376_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00006842-200007000-00012","volume":"65","author":"A Favaro","year":"2000","unstructured":"Favaro A, Caregaro L, Burina AB, Santonastaso P: Tryptophan levels, excessive exercise, and nutritional status in anorexia nervosa. Psychosom Med. 2000, 65: 535-538. 10.1097\/00006842-200007000-00012.","journal-title":"Psychosom Med"},{"key":"376_CR28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.psychres.2005.08.007","volume":"142","author":"KR Bruce","year":"2006","unstructured":"Bruce KR, Steiger H, NG Ying Kin NMK, Israel M: Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology. Psychiatr Res. 2006, 142: 225-232. 10.1016\/j.psychres.2005.08.007.","journal-title":"Psychiatr Res"},{"key":"376_CR29","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.psychres.2006.02.012","volume":"142","author":"A Eckman","year":"2006","unstructured":"Eckman A, Sundblad-Elverfors C, Lande\u00e9n M, Eriksson T, Eriksson E: Low density and high affinity of platelet [3H]paroxetine-binding in women with bulimia nervosa. Psychiatr Res. 2006, 142: 219-233. 10.1016\/j.psychres.2006.02.012.","journal-title":"Psychiatr Res"},{"key":"376_CR30","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1001\/archpsyc.1978.01770280068007","volume":"35","author":"KA Halmi","year":"1978","unstructured":"Halmi KA, Dekirmeniijian H, Davis JM, Casper R, Goldberg S: Catecholamine metabolism in anorexia nervosa. Arch Gen Psychiatr. 1978, 35: 458-460. 10.1001\/archpsyc.1978.01770280068007.","journal-title":"Arch Gen Psychiatr"},{"key":"376_CR31","first-page":"124","volume":"96","author":"DC Jimerson","year":"1988","unstructured":"Jimerson DC, Lesem MD, Kaye WH, Brewerton TD: Symptom severity and neurotransmitter studies in bulimia. Psychopharmacol. 1988, 96: 124-129.","journal-title":"Psychopharmacol"},{"key":"376_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0306-4530(00)00062-7","volume":"26","author":"F Brambilla","year":"2001","unstructured":"Brambilla F, Bellodi L, Arancio C, Ronchi P, Limonta D: Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach. Psychoneuroendocrinol. 2001, 26: 393-409. 10.1016\/S0306-4530(00)00062-7.","journal-title":"Psychoneuroendocrinol"},{"key":"376_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.jpsychires.2006.10.009","volume":"42","author":"J Castro Formieles","year":"2008","unstructured":"Castro Formieles J, Deaulofeu R, Baeza I, Casul\u00e0 V, Saura B, Labaro L, Puig J, Toro J, Bernardo M: Psychopathological and nutritional correlates of plasma homovanillic acid in adolescent with anorexia nervosa. J Psychiatr Res. 2008, 42: 213-220. 10.1016\/j.jpsychires.2006.10.009.","journal-title":"J Psychiatr Res"},{"key":"376_CR34","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.physbeh.2007.11.037","volume":"94","author":"W Kaye","year":"2008","unstructured":"Kaye W: Neurobiology of anorexia and bulimia nervosa. Physiol Behav. 2008, 94: 121-135. 10.1016\/j.physbeh.2007.11.037.","journal-title":"Physiol Behav"},{"key":"376_CR35","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1600-0447.1982.tb04501.x","volume":"66","author":"W Vandereiken","year":"1982","unstructured":"Vandereiken W, Pierlot R: Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study. Acta Psychiatr Scand. 1982, 66: 445-450. 10.1111\/j.1600-0447.1982.tb04501.x.","journal-title":"Acta Psychiatr Scand"},{"key":"376_CR36","doi-asserted-by":"crossref","unstructured":"Vandereiken W: Neuroleptics in the short-term treatment of anorexia nervosa. A double- blind placebo-controlled study with sulpiride. Brit J Psychiatr 1984, 144:288\u2013292.,","DOI":"10.1192\/bjp.144.3.288"},{"key":"376_CR37","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/eat.10130","volume":"33","author":"GB Cassano","year":"2003","unstructured":"Cassano GB, Miniati M, Pini S, Rotondo A, Banti S, Borri C, Camilleri V, Mauri M: Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report. Int J S Six Eat Dis. 2003, 33: 172-177. 10.1002\/eat.10130.","journal-title":"Int J S Six Eat Dis"},{"key":"376_CR38","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1037\/1064-1297.13.1.72","volume":"13","author":"N Mondraty","year":"2005","unstructured":"Mondraty N, Birmingham CL, Touiz S, Sundakov V, Chapman L, Beaumont P: Randomized controlled trial of olanzapine in the treatment of outpatients with bulimia nervosa. J Clin Psychopharmacol. 2005, 13: 72-75. 10.1037\/1064-1297.13.1.72.","journal-title":"J Clin Psychopharmacol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-014-0376-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-014-0376-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-014-0376-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T15:13:30Z","timestamp":1566141210000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-014-0376-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["376"],"URL":"https:\/\/doi.org\/10.1186\/s12888-014-0376-7","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"article-number":"376"}}